Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-2493 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0464 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00 |
filingDate |
2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853db0e3c7162ef565b90cfbc9a4df6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d0a40cccafb871046a5a117dffe4f82 |
publicationDate |
2011-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8002730-B2 |
titleOfInvention |
Anti-thrombogenic venous shunt system and method |
abstract |
A venous shunt system and method adapted to shunt cerebral spinal fluid in a patient. A fluid control device having a fluid passage is adapted to be placed allowing cerebral spinal fluid to flow through the fluid passage. A catheter having a lumen, the catheter being in fluid communication with the fluid control device. At least a portion of at least one of the catheter and the fluid control device being subjected to an anti-thrombogenic treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8740833-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227043-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10773060-B2 |
priorityDate |
2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |